La vendita allo scoperto per Consolidated Comms Hldgs dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Consolidated Comms Hldgs. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Consolidated Comms Hldgs (NASDAQ:CNSL) Azioni, Report sulle vendite allo scoperto

Consolidated Comms Hldgs

Consolidated Communications Holdings Inc provides communication services for business and residential customers across various states in the U.S. Its business product suite includes data and Internet solutions, voice, data center services, security services, managed and IT services, and an expanded suite of cloud services. It provides wholesale solutions to wireless and wireline carriers and other service providers including data, voice, network connections, and custom fiber builds and last-mile connections. It offers residential high-speed Internet, video, phone, and home security services as well as multi-service residential and small business bundles.

Consolidated Communications Holdings, Inc. - Common Stock

Consolidated Communications Holdings Inc

Earnings

Earnings Beats

News

CNSL

Consolidated Comms Hldgs Q3 2024 Adj. EPS $(0.33) Beats $(0.46) Estimate, Sales $271.088M Beat $270.190M Estimate

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.43) by 13.95 percent. The company reported quarterly sales of $268.700 million which missed the analyst consensus estimate of $268.971 million by 0.10 percent. This is a 2.35 percent decrease over sales of $275.162 million the same period last year.

Earnings Misses

Consolidated Comms Hldgs Q2 2024 Adj. EPS $(0.37) Beats $(0.43) Estimate, Sales $268.700M Miss $268.971M Estimate

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.43) by 37.21 percent. The company reported quarterly sales of $274.675 million which beat the analyst consensus estimate of $274.596 million by 0.03 percent. This is a 0.53 percent decrease over sales of $276.126 million the same period last year.

Consolidated Comms Hldgs Q1 2024 Adj EPS $(0.27) Beats $(0.43) Estimate, Sales $274.675M Beat $274.596M Estimate

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 350 points on Tuesday.
The Dow traded down 0.91% to 38,633.24 while the NASDAQ fell 1.85% to 15,906.92. The S&amp;P 500 also fell, dropping, 1.05% to 5,076.98.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37474795/jim-cramer-this-semiconductor-company-is-too-late-to-auto-but-super-micro-is-too-hot"> Jim Cramer: This Semiconductor Company Is &#39;Too Late To Auto,&#39; But Super Micro Is &#39;Too Hot&#39; </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.3% on Tuesday.
In trading on Tuesday, information technology shares fell by 2.2%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Consolidated Communications Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) posted a narrower-than-expected loss for its fourth quarter.
The company reported a fourth-quarter fiscal 2023 revenue decline of 7.0% year-on-year to $275.2 million, missing the analyst consensus of $276.9 million. Adjusted loss of 26 cents beat the analyst consensus loss of 36 cents.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) shares shot up 51% to $32.99 after the company reported a year-over-year increase in fourth-quarter revenue results.
Shares of Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) got a boost, surging 87% to $3.08 after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.
Apogee Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apge#NASDAQ">APGE</a>) shares were also up, gaining 51% to $63.03 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) shares dropped 47% to $1.55 after the company announced the pricing of a $6.5 million public offering.
Shares of ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) were down 23% to $1.8150 after reporting fourth-quarter results.
Crawford &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crd-a#NYSE">CRD-A</a>) was down, falling 27% to $9.13 after the company reported worse-than-expected fourth-quarter financial results.
Also Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37481225/wall-streets-most-accurate-analysts-say-buy-these-3-real-estate-stocks-with-over-3-divid"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Real Estate Stocks With Over 3% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1% to $77.95 while gold traded up 0.5% at $2,137.60.
Silver traded rose 0.1% to $24.00 on Tuesday while copper fell 0.4% to $3.8435.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mixed today. The eurozone&rsquo;s STOXX 600 fell 0.23%, London&rsquo;s FTSE 100 rose 0.08% while Spain&rsquo;s IBEX 35 Index rose 0.47% The German DAX declined 0.10% French CAC 40 fell 0.30% while Italy&rsquo;s FTSE MIB Index rose 0.71%.
Industrial producer prices in the Eurozone fell by 8.6% year-over-year in January, compared to a revised 10.7% decline in the prior month. The eurozone services PMI rose to 50.2 in February versus a preliminary level of 50.
The HCOB German services PMI was revised higher to 48.3 in February versus a preliminary reading of 48.2, while French services PMI climbed to 48.4 in February from 45.4 a month ago. The S&amp;P Global UK services PMI was revised down to 53.8 in February compared to a preliminary reading of 54.3.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Tuesday, with Japan&rsquo;s Nikkei 225 falling 0.03%, Hong Kong&rsquo;s Hang Seng Index dipping 2.61%, China&rsquo;s Shanghai Composite Index gaining 0.28% and India&rsquo;s S&amp;P BSE Sensex declining 0.26%.
The Chinese government said it sees GDP increasing around 5% in 2024, unchanged from the previous year. The Caixin China general service PMI fell to 52.5 in February from 52.7 in January.
The HSBC Indian services PMI fell to 60.6 in February from a preliminary reading of 62.0. The au Jibun Bank Japan services PMI rose to 52.9 in February versus preliminary reading of 52.5. The S&amp;P Global Hong Kong SAR PMI fell to 49.7 in February versus 49.9 a month ago.
&nbsp;
<h3>Economics</h3>
&nbsp;
The Logistics Manager&rsquo;s Index in the U.S. rose to a reading of 56.5 in February, notching the strongest reading in four months.
The S&amp;P Global services PMI was revised higher to 52.3 in February compared to a preliminary reading of 51.3.
The S&amp;P Global composite PMI rose to 52.5 in February versus a preliminary reading of 51.4.
U.S. factory orders fell by 3.6% month-over-month in January compared to a revised 0.3% decline in December.
The ISM services PMI declined to 52.6 in February versus a four-month high level of 53.4 in January and down from market estimates of 53.
Now Read This: <a href="https://www.benzinga.com/news/24/03/37481199/wayfair-snap-and-2-other-stocks-insiders-are-selling"> Wayfair, Snap And 2 Other Stocks Insiders Are Selling </a>

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

AISP

APGE

CRD-A

DAVE

QNRX

TDUP

Crude Oil Down 1%; Dave Shares Jump After Q4 Results

Consolidated Communications Holdings Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) reported a fourth-quarter fiscal 2023 revenue decline of 7.0% year-on-year to $275.2 million, missing the analyst&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/03/b37479323/consolidated-communications-announces-fourth-quarter-and-full-year-2023-financial-results" rel="noreferrer noopener">consensus of $276.9 million</a>.
Adjusted EPS loss of $(0.26) beat the analyst&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus loss of $(0.36)</a>.
Revenue from the Consumer segment declined 1.2% Y/Y to $ 113.85 million as growth in Broadband was offset by a decline in Voice and Video services.
Due to Data and Voice services decline, Commercial segment revenue decreased 5.4% Y/Y to $96.21 million.
Carrier segment revenue declined 7.8% Y/Y to $34.82 million due to Data and Voice services decline.
Adjusted EBITDA declined 14.7% Y/Y to $86.7 million. The margin declined 285 bps to 31.5%.
CNSL generated $11.99 million in operating cash flow and held $4.8 million in cash and equivalents.
Capital expenditures totaled $91.5 million, driven by 49,132 new fiber passings, fourth-quarter fiber adds.
Investors can gain exposure to the stock via&nbsp;Invesco S&amp;P SmallCap Utilities &amp; Communication Services ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSCU#NASDAQ">PSCU</a>) and&nbsp;Syntax Stratified SmallCap ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSLY#NYSE">SSLY</a>).
CNSL Price action: Consolidated Communications Holdings shares were up 0.12% at $4.29 Tuesday morning at publication.
Read Next: <a href="https://www.benzinga.com/news/24/03/37483412/whats-going-on-with-tesla-stock-tuesday">What&#8217;s Going On With Tesla Stock Tuesday?</a>
Photo: Shutterstock

Tech

PSCU

SSLY

Consolidated Communications Holdings Reports Decline In Q4 Earnings Across Key Segments, Adjusted EBITDA Drops 14.7%

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) reported quarterly adjusted losses of $(0.26) per share which beat the analyst consensus estimate of $(0.36) by 27.78 percent. This is a 62.5 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $275.18 million which missed the analyst consensus estimate of $276.94 million by 0.64 percent. This is a 7.03 percent decrease over sales of $295.98 million the same period last year.

Consolidated Comms Hldgs Q4 Adj EPS $(0.26) Beats $(0.36) Estimate, Sales $275.18M Miss $276.94M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
&bull; Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion.
&bull; 2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) is expected to report quarterly loss at $0.99 per share on revenue of $14.71 million.
&bull; CLPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPS#NASDAQ">CLPS</a>) is expected to report earnings for its first quarter.
&bull; Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) is projected to report quarterly loss at $0.50 per share on revenue of $350 thousand.
&bull; Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $183.67 million.
&bull; Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.39 per share on revenue of $2.55 million.
&bull; Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) is likely to report quarterly loss at $0.36 per share on revenue of $276.94 million.
&bull; CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $146.61 million.
&bull; 908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) is expected to report quarterly loss at $0.26 per share on revenue of $14.16 million.
&bull; Neuronetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) is projected to report quarterly loss at $0.26 per share on revenue of $19.85 million.
&bull; Broadwind (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWEN#NASDAQ">BWEN</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.
&bull; Global Business Travel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTG#NYSE">GBTG</a>) is projected to report quarterly loss at $0.03 per share on revenue of $541.17 million.
&bull; Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $84.02 million.
&bull; Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $9.00 million.
&bull; L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $129.35 million.
&bull; Rand Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>) is expected to report earnings for its fourth quarter.
&bull; Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is likely to report earnings for its fourth quarter.
&bull; Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) is projected to report quarterly loss at $0.26 per share on revenue of $17.33 million.
&bull; First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $237.53 million.
&bull; Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $20.00 million.
&bull; SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) is likely to report quarterly loss at $0.01 per share on revenue of $59.49 million.
&bull; Ferguson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) is estimated to report quarterly earnings at $1.85 per share on revenue of $6.77 billion.
&bull; Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $41.78 million.
&bull; Axogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) is likely to report quarterly loss at $0.10 per share on revenue of $41.65 million.
&bull; V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $1.01 billion.
&bull; Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) is likely to report earnings for its fourth quarter.
&bull; Myers Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $196.19 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $197.70 million.
&bull; Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $4.39 billion.
&bull; BlackRock Cap Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKCC#NASDAQ">BKCC</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $20.32 million.
&bull; Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) is likely to report earnings for its fourth quarter.
&bull; Kingsway Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFS#NYSE">KFS</a>) is likely to report earnings for its fourth quarter.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is expected to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) is likely to report earnings for its fourth quarter.
&bull; TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) is likely to report quarterly loss at $0.08 per share on revenue of $1.00 million.
&bull; Entravision Comms (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVC#NYSE">EVC</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $308.47 million.
&bull; Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) is projected to report quarterly loss at $0.87 per share on revenue of $10.58 million.
&bull; Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is likely to report quarterly loss at $3.66 per share on revenue of $73.50 million.
&bull; Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) is expected to report quarterly loss at $0.62 per share on revenue of $8.01 million.
&bull; Allient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNT#NASDAQ">ALNT</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $132.56 million.
&bull; Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) is projected to report quarterly earnings at $0.54 per share on revenue of $329.20 million.
&bull; Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $34.10 million.
&bull; Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) is projected to report quarterly loss at $1.07 per share on revenue of $1.06 million.
&bull; Socket Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCKT#NASDAQ">SCKT</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $4.91 million.
&bull; Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) is expected to report quarterly loss at $0.40 per share on revenue of $1.95 million.
&bull; Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) is likely to report quarterly earnings at $0.55 per share on revenue of $386.45 million.
&bull; W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $138.42 million.
&bull; Cadre Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDRE#NYSE">CDRE</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $121.79 million.
&bull; Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $14.50 million.
&bull; Agiliti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGTI#NYSE">AGTI</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $291.41 million.
&bull; Nuvei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEI#NASDAQ">NVEI</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $319.51 million.
&bull; Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $283.00 million.
&bull; Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $152.30 million.
&bull; Aquestive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQST#NASDAQ">AQST</a>) is likely to report quarterly loss at $0.08 per share on revenue of $11.63 million.
&bull; Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) is expected to report earnings for its fourth quarter.
&bull; MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $74.86 million.
&bull; Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is likely to report earnings for its fourth quarter.
&bull; Cerus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) is expected to report quarterly loss at $0.02 per share on revenue of $49.27 million.
&bull; American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $150.47 million.
&bull; Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $249.68 million.
&bull; Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $13.80 million.
&bull; Aeva Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) is likely to report quarterly loss at $0.15 per share on revenue of $1.57 million.
&bull; LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $127.21 million.
&bull; PlayAGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGS#NYSE">AGS</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $92.57 million.
&bull; Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) is likely to report quarterly loss at $0.14 per share on revenue of $63.13 million.
&bull; CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is expected to report quarterly earnings at $0.82 per share on revenue of $839.04 million.
&bull; HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $149.29 million.
&bull; Banco BBVA Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAR#NYSE">BBAR</a>) is estimated to report earnings for its fourth quarter.
&bull; NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) is expected to report quarterly loss at $0.31 per share on revenue of $17.46 million.
&bull; Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) is projected to report earnings for its fourth quarter.
&bull; Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $61.46 million.
&bull; ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) is likely to report quarterly loss at $0.13 per share on revenue of $119.59 million.
&bull; ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) is expected to report earnings for its fourth quarter.
&bull; NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $63.35 million.
&bull; Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $262.95 million.
&bull; Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) is projected to report earnings for its fourth quarter.
&bull; Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AEVA

AGTI

ALNT

AOMR

APEI

AQST

AXGN

BASE

BBAR

BKCC

BNGO

BWEN

CDRE

CECO

CERS

CGEN

CHPT

CIFR

CLPS

CPIX

CRCT

CRWD

CXDO

FERG

FSTR

FWRG

GBTG

GLRE

ISPO

MASS

MCRB

MLNK

MRNS

NEWT

NPCE

NUWE

NVEI

NYXH

OFIX

OOMA

PKOH

PRST

PSTV

RAND

RIGL

ROST

RSKD

SCKT

SEAT

SMLR

SMRT

SOPH

STIM

TCON

TSVT

VTOL

WEYS

Earnings Scheduled For March 5, 2024

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-05. Here's what investors need to know before the announcement.
Analysts estimate that Consolidated Comms Hldgs will report an earnings per share (EPS) of $-0.36. 
Consolidated Comms Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.06, which was followed by a 0.24% increase in the share price the next day.
Here's a look at Consolidated Comms Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.37</td>
<td>-0.27</td>
<td>-0.23</td>
<td>-0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.31</td>
<td>-0.28</td>
<td>-0.28</td>
<td>-0.16</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709560946_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Consolidated Comms Hldgs were trading at $4.31 as of February 29. Over the last 52-week period, shares are up 50.96%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/CNSL/earnings">To track all earnings releases for Consolidated Comms Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Consolidated Comms Hldgs's Earnings Outlook

Mails Letter to Shareholders Reiterating that Shareholders Should Vote "FOR" the Value Maximizing Transaction TODAY
Consolidated Communications Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) (the "Company" or "Consolidated"), filed an investor presentation with the U.S. Securities and Exchange Commission ("SEC") on January 10, 2024 in connection with the Company's upcoming special meeting of shareholders (the "Special Meeting") on January 31, 2024. The presentation is available on the Company's investor relations website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.consolidated.com%2F&amp;esheet=53880502&amp;newsitemid=20240110179493&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.consolidated.com%2F&amp;index=1&amp;md5=48a3bffed54b72ee04d4df19c3d8c5ba">https://ir.consolidated.com/</a>.
The Company urges its shareholders to vote "FOR" the proposed acquisition of the Company by affiliates of Searchlight Capital Partners, L.P. ("Searchlight") and British Columbia Investment Management Corporation ("BCI") (the "Proposed Transaction"). Shareholders of record as of December 13, 2023, are entitled to vote at the Special Meeting.
Highlights of the presentation include:
<ul>
<li>Transaction offers a compelling valuation, and shifts execution, liquidity, and market risk to buyers
<ul>
<li>All-cash offer at a 70% premium to Consolidated's unaffected1 share price is significantly higher than public and take-private precedent transactions, and exceeds analysts' price targets, despite material sector-wide decline.</li>
<li>Implied 9.6x LTM EBITDA multiple is higher than any Local Exchange Carrier precedent transaction in at least a decade.</li>
<li>Eliminates ongoing uncertainty of liquidity, funding and execution risks, transferring those risks to Searchlight and BCI.</li>
<li>Extensive special committee process over six months examined multiple strategic alternatives and achieved a 17.5% increase in price to the original offer.</li>
</ul>
</li>
<li>Standalone plan carries more downside risk than upside risk
<ul>
<li>Consolidated no longer has the liquidity to fund its prior standalone growth plans and sufficient external financing is not readily available.</li>
<li>Liquidity constraints add serious risk to the Company's capital-intensive fiber transformation, which is a requirement if the Company is to remain competitive and deliver growth.</li>
<li>Time to market is imperative – those who are first to market with fiber offerings will be best-positioned to take and hold significant share. Delays to Consolidated's fiber build due to liquidity constraints cedes its incumbency advantage, presenting potential franchise risk.</li>
</ul>
</li>
<li>Voting down this deal would be disastrous for shareholders
<ul>
<li>Wildcat Capital Management, LLC may dismiss the strategic urgency of our liquidity constraints but if this deal is not approved, the market will not be so forgiving. Peers of Consolidated have traded down, underscoring the market's concern about the challenges Consolidated and its peers face.</li>
<li>Wildcat's analysis fails to account for both the cost and dilutive impact of the additional capital needed to execute the standalone plan and the significant execution risks that fiber conversion presents.</li>
<li>Wildcat has an unrealistic demand for $14.00 per share – a 407% premium over the unaffected stock price.</li>
<li>No other bidders emerged during the well-publicized process or post-announcement of the Proposed Transaction, demonstrating that this is the best deal available.</li>
</ul>
</li>
</ul>
Consolidated also mailed a letter to its shareholders in connection with the Special Meeting. The full text of the letter follows:
January 11, 2024
Dear Fellow Shareholders,
The special committee of independent directors (the "Special Committee") of the Board of Directors of Consolidated Communications Holdings, Inc. (the "Board") is here to answer your questions about the value-maximizing acquisition of the Company proposed by affiliates of Searchlight Capital Partners, L.P. ("Searchlight") and British Columbia Investment Management Corporation ("BCI") (the "Proposed Transaction").
The January 31, 2024 deadline to vote on the Proposed Transaction is fast approaching. You only have one opportunity to protect the value of your investment and realize the benefits.
Vote Your Shares "FOR" Today –
Not Voting Is the Same as Voting Against the Proposed Transaction
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Why should I vote FOR the deal?</td>
<td colspan="1" rowspan="1">
Casting your vote is the best way for you to secure this compelling cash premium.
&nbsp;
Our standalone plan carries significant downside risk due to our constrained liquidity position and limited access to capital. We are simply unable to fund future fiber builds at the pace necessary to remain competitive and to continue to grow.
&nbsp;
The Proposed Transaction eliminates the real risk that shareholders face if Consolidated were to remain public, and transfers all liquidity, financing and execution risks to Searchlight and BCI.
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Is this my best option?</td>
<td colspan="1" rowspan="1">
We believe so, yes.
&nbsp;
The Special Committee completed an exhaustive evaluation of all opportunities to maximize value for shareholders, meeting more than 35 times over a six-month period. The process was public and highly visible from the moment Searchlight and BCI submitted their initial non-binding proposal to the Board. No parties expressed interest in bidding despite this long and public process.
&nbsp;
The Special Committee's robust evaluation underscores that the Proposed Transaction is the most compelling path forward for Consolidated and its shareholders.
&nbsp;
The $4.70 per share all-cash offer is:
<ul>
<li>A 70% premium to our unaffected share price1</li>
<li>Significantly higher than certain recent public and take private precedent transactions</li>
<li>Significantly higher than analysts' price targets prior to the unaffected date1</li>
</ul>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">What happens if I don't vote?</td>
<td colspan="1" rowspan="1">
If we do not get enough votes in favor to approve the transaction, it will fail and Consolidated's share price is at risk of dropping significantly below the pre-announcement price.
&nbsp;
Maximize the value of your investment and vote "FOR" the Proposed Transaction today.
&nbsp;
Your vote is extremely important, regardless of how many shares you own. Every vote counts and is critical to the future of the Company. Not voting is the same as voting against the transaction.
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
How do I vote?
&nbsp;
</td>
<td colspan="1" rowspan="1">
Consolidated shareholders have three quick and easy ways to vote "FOR" the Proposed Transaction up until 11:59 p.m. ET the day before the cut-off date or meeting date:
&nbsp;
<ul>
<li>Vote Online: Before the meeting, go to proxyvote.com or scan the QR code on your card. Have your proxy card in hand and follow the instructions.</li>
<li>Vote By Mail: Mark, sign and date the proxy card and return it in the postage-paid envelope provided.</li>
<li>Vote By Phone: Dial 1-800-690-6903 on any touch-tone telephone. Have your proxy card in hand and follow the instructions.</li>
</ul>
&nbsp;
Don't delay. We recommend that you vote promptly, even if you plan to attend the special meeting of shareholders.
</td>
</tr>
</tbody>
</table>
</figure>
As a Consolidated shareholder, your choice is clear: vote for significant, compelling and certain value. Vote "FOR" the Proposed Transaction today.
We thank you for your continued support.
Sincerely,
The Special Committee of the Board of Directors of Consolidated Communications Holdings, Inc.

Events

Consolidated Communications Files Investor Presentation Highlighting Benefits Of Proposed Transaction With Searchlight And BCI

Consolidated Communications Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) (the "Company" or "Consolidated"), has mailed a letter to its shareholders in connection with its upcoming special meeting of shareholders (the "Special Meeting") urging its shareholders to vote "FOR" the proposed acquisition of the Company by affiliates of Searchlight Capital Partners, L.P. ("Searchlight") and British Columbia Investment Management Corporation ("BCI") (the "Proposed Transaction"). The Special Meeting is scheduled to be held on January 31, 2024. Shareholders of record as of December 13, 2023, are entitled to vote at the Special Meeting.
The full text of the letter mailed to shareholders follows:
December 27, 2023
Dear Fellow Shareholders,
You have an essential decision to make regarding the value of your investment. In order to realize the benefits of this value-maximizing transaction, the majority of our independent shareholders must support the deal. This means that your vote is extremely important, regardless of the number of shares you own. Every vote counts and is critical to the future of the Company. Not voting is the same as voting against the transaction.
The board of directors of the Company (the "Board") strongly believes the $4.70 per share cash offer from Searchlight and BCI is the best risk-adjusted outcome for shareholders and urges that you vote "FOR" the Proposed Transaction.
Proposed Transaction Offers Financially Compelling and Certain Value
<ul>
<li>$4.70 per share in cash eliminates the real risk that shareholders face if the Company were to remain standalone</li>
<li>70% premium to Consolidated's share price as of April 12, 20231</li>
<li>89% premium to one-month VWAP2</li>
<li>18% increase in price achieved through negotiations following the initial bid from Searchlight and BCI</li>
<li>Purchase price is higher than Consolidated's stock price at every point over the last year, even after Searchlight and BCI's initial bid was made public, which underscores the value of this transaction</li>
</ul>
_________________
1 The last full trading day prior to submission of Searchlight and BCI's initial non-binding proposal. 2 Calendar day volume-weighted average prices as of April 12, 2023. &nbsp;
Transaction Multiple is Attractive Relative to Other Incumbent Communications Provider Transactions
<ul>
<li>The implied 9.6x LTM EBITDA multiple secured by the Special Committee is higher than ANY incumbent communications provider precedent transaction in a decade</li>
<li>While the Special Committee was negotiating an increase in price, other communications providers were experiencing a material decline in value, with six of eight peers seeing share price declines3</li>
</ul>
Special Committee Undertook a Robust Evaluation of All Opportunities to Maximize Value for the Company's Shareholders
A special committee composed of independent and disinterested directors, and advised by independent legal and financial advisors (the "Special Committee"), completed a comprehensive evaluation of Searchlight and BCI's proposal, as well as all other possible go-forward alternatives.
<ul>
<li>The process was public and highly visible from the moment Searchlight and BCI submitted their initial non-binding proposal to the Board</li>
<li>The Special Committee announced a formal review of all potential strategic alternatives</li>
<li>More than 35 Special Committee meetings were held to consider the transaction and possible alternatives</li>
<li>0 parties expressed interest in bidding despite a long and public process</li>
</ul>
Proposed Transaction Will Transfer Any Execution Risks to Searchlight and BCI
Consolidated's transition from copper DSL lines to fiber is competitively critical, and there is significant execution risk, especially given the deteriorating financing and operating environment. We no longer have the liquidity to fund our original growth plan, and time to market is imperative. Those who are first to the market with fiber services will be able to take and maintain a significant market share.
Following its extensive and thorough review, the Board believes this transaction is critical for Consolidated's future and represents the best risk-adjusted outcome for its shareholders.
Vote Your Shares to Maximize the Value of Your Investment
As a Consolidated Shareholder, Your Choice is Clear: Vote "FOR" Significant, Compelling and Immediate Value.
The Special Meeting is fast approaching and is being held on January 31, 2024. The Proposed Transaction will deliver financially compelling and certain value to shareholders.
Failure to vote FOR the Proposed Transaction, including not voting at all, could result in the deal failing and Consolidated's share price falling to well below the pre-announcement price. Maximize the value of your investment and vote "FOR" the Proposed Transaction.
_________________
3 Share price returns for select peers reflect changes since April 12, 2023, the day before Searchlight and BCI's non-binding offer was made public, through October 13, 2023, the last full trading day prior to announcement of entry into the merger agreement. Peers include Frontier Communications Parent, Inc., Lumen Technologies, Inc., Cable One, Inc., Shenandoah Telecommunications Company, ATN International, WideOpenWest, Inc., Altice USA, Inc. and Charter Communications, Inc.
Shareholders with questions or who require assistance voting their shares should contact Consolidated's proxy solicitor, Morrow Sodali. Shareholders may call toll-free: (800) 662-5200 or +1 (203) 658-9400 (international) or email <a href="mailto:CNSL@info.morrowsodali.com">CNSL@info.morrowsodali.com</a>.

Consolidated Communications Reiterates Proposed Transaction Is The Best Outcome For Shareholders; Shareholders Will Avoid Risk And Maximize The Value Of Their Shares By Voting For The Proposed Transaction

Urges Shareholders to Protect Their Investments by Voting FOR the Proposed Transaction
Consolidated Communications Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) (the "Company" or "Consolidated"), a top 10 fiber provider in the U.S., today announced that it has filed its definitive proxy statement. The Company has also filed a letter to shareholders in connection with its upcoming special meeting of shareholders (the "Special Meeting") urging shareholders to vote "FOR" the proposed acquisition of the Company by affiliates of Searchlight Capital Partners, L.P. ("Searchlight") and British Columbia Investment Management Corporation ("BCI") (the "Proposed Transaction"). The Special Meeting is scheduled to be held on January 31, 2024, and shareholders of record as of December 13, 2023 will be entitled to vote at the meeting.
This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20231217888743/en/">https://www.businesswire.com/news/home/20231217888743/en/</a>
1. Unaffected stock price as of April 12, 2023, the last trading day prior to public announcement of the non-binding proposal. 2. Peers include Frontier Communications, Lumen, Cable One, Shentel, ATN International, WideOpenWest, Altice USA and Charter Communications. 3. Calendar day volume-weighted average prices as of April 12, 2023.
The Consolidated board of directors (the "Board") believes the offer of $4.70 per share represents the best risk-adjusted outcome for shareholders, particularly in light of the significant risks associated with Consolidated's prospects as a public company with limited access to capital. The Board urges shareholders to vote "FOR" the Proposed Transaction. Highlights from the letter include:
<ul>
<li>The Proposed Transaction delivers a significant cash premium, representing a compelling opportunity for shareholders to receive an attractive and certain value for their investment.
<ul>
<li>Even as peer stock prices have fallen, the purchase price exceeds Consolidated's stock price at every point over the last year, even after the initial bid was made public, underscoring the value-maximizing nature of the Proposed Transaction.</li>
</ul>
</li>
<li>The Proposed Transaction eliminates the ongoing uncertainty from liquidity, funding and execution risks and transfers those risks to Searchlight and BCI.
<ul>
<li>The operating environment makes it difficult and costly for Consolidated to execute its strategy, and Consolidated does not have the liquidity to fund its future fiber builds at the pace necessary to remain competitive.</li>
<li>By slowing the Company's fiber build pace, which it needs to do in 2024 to preserve liquidity, competitors will have additional time to build fiber in certain of Consolidated's markets ahead of the Company, creating a clear competitive disadvantage and an impediment to future growth.</li>
</ul>
</li>
<li>The special committee established by the Board, composed of independent and disinterested directors, undertook a robust and thorough evaluation of all opportunities, including continuing as a standalone company, and determined that the Proposed Transaction is the most compelling – and only viable – path forward.</li>
<li>Wildcat's perspective is based on incomplete information, and a misunderstanding of the risks and opportunities facing the Company. Wildcat has based its views on hypothetical and highly uncertain long-term scenarios for Consolidated that ignore the near-term realities of operational risk, competitive intensity and financing uncertainty that the Company faces today. Following Wildcat's misguided perspective would only endanger the value and certainty that shareholders will receive if they support the Proposed Transaction.</li>
</ul>

Consolidated Communications Files Letter To Shareholders Highlighting Benefits Of Proposed Transaction With Searchlight And BCI; Urges Shareholders To Vote For The Proposed Transaction

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) reported quarterly losses of $(0.61) per share. This is a 369.23 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $283.65 million which beat the analyst consensus estimate of $274.23 million by 3.44 percent. This is a 4.37 percent decrease over sales of $296.62 million the same period last year.

Consolidated Comms Hldgs Q3 EPS $(0.61) Down From $(0.13) YoY, Sales $283.65M Beat $274.23M Estimate

<h3>Gainers</h3>
<ul>
<li>Mobile Global Esports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGAM#NASDAQ">MGAM</a>) shares moved upwards by 10.0% to $0.38 during Monday's after-market session. The market value of their outstanding shares is at $7.6 million. </li>
<li>EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) shares moved upwards by 9.54% to $8.15. The company's market cap stands at $271.9 million. The company's, Q3 earnings came out today. </li>
<li>TripAdvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) stock increased by 8.75% to $17.52. TripAdvisor's trading volume hit 832.7K shares by close, accounting for 35.6% of its average volume over the last 100 days. The company's market cap stands at $2.4 billion. The company's, Q3 earnings came out today. </li>
<li>Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) stock increased by 7.16% to $3.59. Vimeo's trading volume hit 55.9K shares by close, accounting for 6.0% of its average volume over the last 100 days. The company's market cap stands at $599.0 million. As per the news, the Q3 earnings report came out today. </li>
<li>DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) stock moved upwards by 3.28% to $0.87. At the close, DouYu Intl Hldgs's trading volume reached 126.9K shares. This is 36.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $278.2 million. </li>
<li>Altice USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) stock moved upwards by 2.85% to $2.52. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Salem Media Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SALM#NASDAQ">SALM</a>) shares fell 8.2% to $0.71 during Monday's after-market session. The company's market cap stands at $19.2 million. </li>
<li>Charge Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGE#NASDAQ">CRGE</a>) shares fell 6.9% to $0.39. The company's market cap stands at $83.0 million. </li>
<li>Atlanta Braves Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BATRA#NASDAQ">BATRA</a>) shares decreased by 5.18% to $37.36. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Atlanta Braves Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BATRK#NASDAQ">BATRK</a>) stock fell 4.05% to $34.6. Today's trading volume for this security ended up closing at 369.3K shares, which is 167.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $2.1 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Clear Channel Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) stock fell 3.58% to $1.08. Today's trading volume for this security ended up closing at 60.8K shares, which is 1.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $521.5 million. </li>
<li>Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) shares declined by 3.33% to $4.07. The company's market cap stands at $474.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ATUS

BATRA

BATRK

CRGE

DOYU

EVER

MGAM

SALM

TRIP

VMEO

12 Communication Services Stocks Moving In Monday's After-Market Session

Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) is set to give its latest quarterly earnings report on Tuesday, 2023-11-07. Here's what investors need to know before the announcement.
Analysts estimate that Consolidated Comms Hldgs will report an earnings per share (EPS) of $-0.37. 
Consolidated Comms Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.01, which was followed by a 1.79% increase in the share price the next day.
Here's a look at Consolidated Comms Hldgs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.27</td>
<td>-0.23</td>
<td>-0.17</td>
<td>-0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.28</td>
<td>-0.28</td>
<td>-0.16</td>
<td>-0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.79%</td>
<td>-2.31%</td>
<td>-4.95%</td>
<td>-5.23%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1699286475_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Consolidated Comms Hldgs were trading at $4.25 as of November 03. Over the last 52-week period, shares are down 13.51%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CNSL/earnings">To track all earnings releases for Consolidated Comms Hldgs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Consolidated Comms Hldgs

Consolidated Communications Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) shares are trading higher after the company announced an agreement to be acquired by Searchlight Capital Partners and <a href="https://www.benzinga.com/pressreleases/23/10/b35264630/consolidated-communications-announces-agreement-to-be-acquired-by-searchlight-capital-partners-and">British Columbia Investment Management</a>.
What To Know: The acquisition will be an all-cash transaction with an enterprise value of approximately $3.1 billion, including the assumption of debt.
Searchlight and BCI will acquire all of the Consolidated common stock not already owned by Searchlight for $4.70 per share in cash, under the terms of the agreement. Furthermore, it will result in Consolidated Communications becoming a private company and thus shares of the company&#39;s common stock will no longer be traded or listed on any public securities exchange.
The transaction is is expected to close by the first quarter of 2025.
Related Link: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35271998/uks-economic-secretary-challenges-new-crypto-advertising-regulations">UK&#39;s Economic Secretary Challenges New Crypto Advertising Regulations</a>
CNSL Price Action: Shares of CNSL were up 16.0% at $4.10 at the time of publication, according to <a href="http://pro.benzinga">Benzinga Pro</a>.
Image by <a href="https://pixabay.com/users/wir_pixs-11762968/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=7409591">Wilfried Pohnke</a> from <a href="https://pixabay.com//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=7409591">Pixabay</a>

Why Consolidated Communications Holdings Stock Is Higher Today

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining over 1% on Monday.
The Dow traded up 0.93% to 33,983.22 while the NASDAQ rose 1.31% to 13,582.67. The S&amp;P 500 also rose, gaining, 1.11% to 4,375.72.
Check This Out: <a href="https://www.benzinga.com/news/23/10/35265545/top-3-health-care-stocks-that-may-implode-this-quarter"> Top 3 Health Care Stocks That May Implode This Quarter </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer discretionary shares climbed by 1.4% on Monday.
In trading on Monday, energy shares rose by just 0.6%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The Charles Schwab Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schw#NYSE">SCHW</a>) reported better-than-expected earnings for the third quarter.
The company posted quarterly net revenue decline of 16% year-over-year to $4.61 billion, missing the consensus of $4.63 billion. Adjusted EPS stood at $0.77, down 30% Y/Y, exceeding the consensus of $0.75.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Consolidated Communications Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) shares shot up 16% to $4.10 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.
Shares of PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) got a boost, shooting 47% to $6.86. On Friday, Amphenol Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aph#NYSE">APH</a>) inked a deal to acquire PCTEL for around $139.7 million.
E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) shares were also up, gaining 24% to $3.0450. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) shares dropped 67% to $1.8050. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.
Shares of Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) were down 68% to $0.2347 after the company announced it is undergoing a strategic restructuring to cut expenses.
Omeros Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) was down, falling 32% to $1.5350 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35267375/jpmorgan-to-rally-over-29-here-are-10-other-analyst-forecasts-for-monday"> JPMorgan To Rally Over 29%? Here Are Top 10 Analyst Forecasts For Monday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.8% to $87.11 while gold traded down 0.4% at $1,934.00.
Silver traded down 0.5% to $22.79 on Monday while copper rose 0.4% to $3.5860.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed higher today. The eurozone&rsquo;s STOXX 600 rose 0.23%, London&rsquo;s FTSE 100 rose 0.41% while Spain&rsquo;s IBEX 35 Index rose 0.59% The German DAX rose 0.34% French CAC 40 rose 0.27%, while Italy&rsquo;s FTSE MIB Index gained 0.55%.
The Eurozone recorded a trade surplus of EUR 6.7 billion in August versus a year-ago gap of EUR 54.4 billion. The annual inflation rate in Italy eased to 5.3% in September from 5.4% a month ago. German wholesale prices fell for the sixth straight period by 4.1% year-over-year in September.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed lower on Monday, with Japan&rsquo;s Nikkei 225 falling 2.03%, China&rsquo;s Shanghai Composite Index falling 0.46% and Hong Kong&rsquo;s Hang Seng Index dropping 0.97%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, slipped 0.2%.
India&#39;s wholesale prices fell by 0.26% year-over-year in September following a 0.52% decline in the previous month. Industrial production in Japan fell by 0.7% month-over-month in August.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index declined to -4.6 in October from 1.9 in the prior month, compared to market estimates for a reading of -7.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35266700/rain-oncology-and-3-other-stocks-under-1-insiders-are-buying"> Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying</a>

ALDX

ETWO

OMER

PCTI

SCHW

STRM

Crude Oil Moves Lower; Consolidated Communications Shares Jump

<h3>Gainers</h3>
<ul>
<li>Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) shares increased by 16.3% to $4.11 during Monday's regular session. Consolidated Comms Hldgs's stock is trading at a volume of 3.6 million shares as of 13:30 EST. This is 851.3% of its average full-day volume over the last 100 days. The company's market cap stands at $478.6 million. </li>
<li>E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) stock increased by 14.0% to $5.78. Trading volume for this security as of 13:30 EST is 351.0K, which is 86.1% of its average full-day volume over the last 100 days. The company's market cap stands at $488.2 million. </li>
<li>Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) stock rose 11.8% to $9.71. As of 13:30 EST, this security is trading at a volume of 39.9 million shares, making up 164.3% of its average full-day volume over the last 100 days. The company's market cap stands at $15.7 billion. </li>
<li>Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) stock rose 11.42% to $4.68. As of 13:30 EST, this security is trading at a volume of 301.5K shares, making up 74.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $99.0 million. </li>
<li>SPAR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) shares increased by 11.31% to $0.98. The market value of their outstanding shares is at $22.7 million. </li>
<li>EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) stock rose 11.03% to $8.05. As of 13:30 EST, this security is trading at a volume of 183.6K shares, making up 70.9% of its average full-day volume over the last 100 days. The company's market cap stands at $268.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NFT Gaming Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFTG#NASDAQ">NFTG</a>) shares declined by 22.8% to $0.74 during Monday's regular session. Trading volume for this security as of 13:30 EST is 2.7 million, which is 552.9% of its average full-day volume over the last 100 days. The company's market cap stands at $8.9 million. </li>
<li>Oriental Culture Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) shares declined by 16.1% to $0.26. The market value of their outstanding shares is at $5.5 million. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) shares declined by 10.47% to $0.48. Trading volume for this security as of 13:30 EST is 93.7K, which is 102.6% of its average full-day volume over the last 100 days. The company's market cap stands at $6.6 million. </li>
<li>FaZe Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAZE#NASDAQ">FAZE</a>) stock fell 9.92% to $0.21. FaZe Hldgs's stock is trading at a volume of 246.9K shares as of 13:30 EST. This is 12.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.0 million. </li>
<li>Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) stock fell 9.61% to $18.06. The current volume of 5.1 million shares is 433.7% of Manchester United's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $2.9 billion. </li>
<li>Emerald Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) shares decreased by 8.27% to $5.28. Emerald Holding's stock is trading at a volume of 76.5K shares as of 13:30 EST. This is 78.3% of its average full-day volume over the last 100 days. The company's market cap stands at $331.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASST

FAZE

MANU

NFTG

SGRP

SKLZ

SNAP

12 Communication Services Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) shares gained 64% to $0.7798 after gaining more than 10% on Friday.</li>
<li>PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) climbed 47.3% to $6.86. On Friday, Amphenol Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aph#NYSE">APH</a>) inked a deal to acquire PCTEL for around $139.7 million.</li>
<li>Almacenes &Eacute;xito S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/exto#NYSE">EXTO</a>) shares rose 32.6% to $6.66.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) surged 30% to $0.7608.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpst#NASDAQ">TPST</a>) gained 29% to $4.72.</li>
<li>LQR House Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lqr#NASDAQ">LQR</a>) shares climbed 24.5% to $0.2148. LQR House announced that through its custom marketing campaign and strategic efforts, Von Payne Whiskey is now displayed on the shelves of the retail giant, Costco.</li>
<li>Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) rose 23% to $0.7868 after declining 37% on Friday.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) climbed 22.2% to $1.76.</li>
<li>E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) gained 22% to $3.00. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.</li>
<li>Inotiv, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/notv#NASDAQ">NOTV</a>) climbed 21.2% to $2.4850.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zapp#NASDAQ">ZAPP</a>) gained 21.2% to $0.6195.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) shares jumped 20.8% to $0.5799 after jumping 45% on Friday.</li>
<li>Mereo BioPharma Group plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mreo#NASDAQ">MREO</a>) climbed 20% to $1.55. Ultragenyx and Mereo BioPharma announced interim Phase 2 data from Phase 2/3 Orbit study demonstrating setrusumab significantly reduced fracture rates in patients with osteogenesis imperfecta.</li>
<li>Prothena Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prta#NASDAQ">PRTA</a>) gained 19.7% to $52.78.</li>
<li>Alignment Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alhc#NASDAQ">ALHC</a>) gained 17.8% to $7.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.</li>
<li>Consolidated Communications Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) surged 17.5% to $4.1493 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.</li>
<li>Modular Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/modd#NASDAQ">MODD</a>) gained 17.4% to $1.08.</li>
<li>Catalyst Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) rose 15.5% to $0.39.</li>
<li>indie Semiconductor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indi#NASDAQ">INDI</a>) climbed 15% to $5.60. indie Semiconductor expects third-quarter revenue to be above $60 million, slightly higher than the company&#39;s guidance and consensus estimates.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsp#NASDAQ">CNSP</a>) gained 14.2% to $1.5527.</li>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) shares rose 13.8% to $0.3639 after falling 14% on Friday.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) climbed 11.9% to $12.35.</li>
<li>MoonLake Immunotherapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mltx#NASDAQ">MLTX</a>) gained 11.5% to $60.98 after the company announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab.</li>
<li>NanoVibronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naov#NASDAQ">NAOV</a>) surged 11.5% to $1.2828.</li>
<li>ATRenew Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rere#NYSE">RERE</a>) climbed 11.3% to $1.78.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares gained 10.8% to $3.4450.</li>
<li>Overstock.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ostk#NASDAQ">OSTK</a>) climbed 10.5% to $16.61. Overstock.com 13D filing showed JAT Capital Mgmt LP reported a 9.1% stake in the company as of Oct. 12.</li>
<li>Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) surged 9.8% to $414.67 after it was announced the stock will join the S&amp;P 500.</li>
<li>ESSA Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/epix#NASDAQ">EPIX</a>) gained 8.4% to $2.9696.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) climbed 8.4% to $9.40.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) shares dipped 68.2% to $0.2350 after the company announced it is undergoing a strategic restructuring to cut expenses.</li>
<li>Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) shares fell 66.7% to $1.81. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.</li>
<li>Biocept, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bioc#NASDAQ">BIOC</a>) fell 46% to $0.5503. Biocept said Antonino Morales tendered his resignation as the company&#39;s President And Chief Executive Officer, effective on Oct. 13, 2023. The company also filed voluntary petition under the provisions of Chapter 7 in Bankruptcy Court.</li>
<li>Omeros Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) dropped 37.4% to $1.42 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.</li>
<li>Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) fell 36.2% to $8.97. Ambrx Biopharma said that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01 of ARX517 for metastatic castration-resistant prostate cancer were made available at the European Society of Medical Oncology.</li>
<li>The NFT Gaming Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nftg#NASDAQ">NFTG</a>) declined 35.3% to $0.6255.</li>
<li>Sigma Additive Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sasi#NASDAQ">SASI</a>) fell 32.8% to $3.99 after jumping 140% on Friday.</li>
<li>Shift Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sft#NASDAQ">SFT</a>) shares fell 30.3% to $0.11. Maruthi J. D. Venkata reported a 4.8% stake in Shift Technologies as of Oct 12, 2023 versus an 11.5% stake reported as of March 14, 2023.</li>
<li>Vista Outdoor Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsto#NYSE">VSTO</a>) declined 24.6% to $24.72 after the company lowered FY24 guidance and announced it entered into a definitive agreement to sell its sporting products business.</li>
<li>RVL Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvlp#NASDAQ">RVLP</a>) declined 23% to $0.0557. RVL Pharmaceuticals said on Oct. 12, that the company received delisting notice from Listing Qualifications Department of Nasdaq Stock Market LLC.</li>
<li>Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) fell 22% to $0.3664. Nexalin Technology announced publication of groundbreaking deep-brain stimulation study in leading peer-reviewed journal.</li>
<li>Elys Game Technology, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elys#NASDAQ">ELYS</a>) declined 21.4% to $0.4050.</li>
<li>ShiftPixy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pixy#NASDAQ">PIXY</a>) fell 20.6% to $13.60.</li>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) fell 16.5% to $0.1956. Versus Systems reported pricing of $3.0 million public offering.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) fell 15.5% to $0.0769.</li>
<li>MoneyHero Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mny#NASDAQ">MNY</a>) declined 15.5% to $2.83.</li>
<li>UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) shares fell 12.7% to $0.2750, after gaining over 7% on Friday.</li>
<li>FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 11.8% to $0.2056 after jumping around 25% on Friday.</li>
<li>Tango Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tngx#NASDAQ">TNGX</a>) declined 11.5% to $6.80.</li>
<li>Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) declined 10.8% to $0.9181.</li>
<li>Procaps Group S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/proc#NASDAQ">PROC</a>) fell 9.7% to $2.5444.</li>
<li>Manchester United plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/manu#NYSE">MANU</a>) shares fell 9.5% to $18.08 after a Qatari investor group led by Sheikh Jassim Bin Hamad J.J. Al Thani reportedly withdrew its bid to acquire the club.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpth#NASDAQ">BPTH</a>) shares fell 9.3% to $0.6804 after jumping around 111% on Friday.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) declined 7.9% to $6.49. Shares of vaccine stocks traded lower after Pfizer reduced its 2023 COVID vaccine revenue outlook.</li>
<li>ParaZero Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/przo#NASDAQ">PRZO</a>) shares fell 7.6% to $3.05, after jumping 55% on Friday.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) declined 4.7% to $14.22. GameStop General Counsel and Secretary Haymond Mark Robinson sold a total of 11,966 shares at an average price of $15.48.</li>
<li>BioNTech SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntx#NASDAQ">BNTX</a>) fell 4.1% to $99.34 after the company&#39;s partner, Pfizer, cut its COVID-19 vaccine and therapy sales outlook.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/10/35263270/tesla-options-trading-surges-ahead-of-wednesday-earnings-report"> Tesla Options Trading Surges Ahead Of Wednesday Earnings Report</a>

ALHC

AMAM

BIOC

BNTX

BPTH

CBIO

CDLX

CLOV

CNSP

ELYS

ENSC

EPIX

EXTO

INDI

LULU

MLTX

MNTS

MODD

MREO

NAOV

NOTV

NVAX

OSTK

PCSA

PIXY

PROC

PRTA

PRZO

RDHL

RERE

RVLP

SASI

SECO

TNGX

Tempest Therapeutics, Inc. - Common Stock

TPST

VSTO

YGMZ

ZAPP

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today&rsquo;s session.
PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) gained 47.3% to $6.86. On Friday, Amphenol Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aph#NYSE">APH</a>) inked a deal to acquire PCTEL for around $139.7 million.
Almacenes &Eacute;xito S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/exto#NYSE">EXTO</a>) shares climbed 32.6% to $6.66.
E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) rose 22% to $3. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.
Prothena Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prta#NASDAQ">PRTA</a>) climbed 19.7% to $52.78.
Alignment Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alhc#NASDAQ">ALHC</a>) rose 17.8% to $7.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.
Consolidated Communications Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) gained 17.5% to $4.1493 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.
indie Semiconductor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indi#NASDAQ">INDI</a>) jumped 15% to $5.60. indie Semiconductor expects third-quarter revenue to be above $60 million, slightly higher than the company&#39;s guidance and consensus estimates.
MoonLake Immunotherapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mltx#NASDAQ">MLTX</a>) rose 11.5% to $60.98 after the company announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab.
ATRenew Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rere#NYSE">RERE</a>) gained 11.3% to $1.78.
Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) climbed 11.3% to $33.30 after the company on Friday announced preliminary clinical data for RMC-6236 and RMC-6291.
SunOpta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stkl#NASDAQ">STKL</a>) rose 11.2% to $3.9450.
Overstock.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ostk#NASDAQ">OSTK</a>) surged 10.5% to $16.61. Overstock.com 13D filing showed JAT Capital Mgmt LP reported a 9.1% stake in the company as of Oct. 12.
Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) climbed 9.8% to $414.67 after it was announced the stock will join the S&amp;P 500.
Puyi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) jumped 8.8% to $5.68.
Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) gained 8.4% to $9.40.
Tuya Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tuya#NYSE">TUYA</a>) rose 8.3% to $1.6350.
QuinStreet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnst#NASDAQ">QNST</a>) climbed 7.8% to $10.08.
Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) gained 7.6% to $12.30.
Trinity Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trn#NYSE">TRN</a>) rose 7.4% to $23.52. Susquehanna upgraded Trinity Industries from Neutral to Positive and raised the price target from $29 to $32.
Varonis Systems&nbsp;Inc&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrns#NASDAQ">VRNS</a>) gained 7.3% to $32.80 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
Sinclair, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbgi#NASDAQ">SBGI</a>) climbed 7.2% to $10.43.
SMART Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgh#NASDAQ">SGH</a>) gained 6.6% to $13.97.
Market gains and prices at the time of writing.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35267829/ethereum-tops-this-key-level-bitcoin-sv-emerges-as-top-gainer"> Ethereum Tops This Key Level; Bitcoin SV Emerges As Top Gainer</a>
Photo: Shutterstock

PUYI

QNST

RVMD

SBGI

STKL

TUYA

VRNS

Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday.
The Dow traded up 1.02% to 34,012.79 while the NASDAQ rose 1% to 13,541.79. The S&amp;P 500 also rose, gaining, 1.03% to 4,372.52.
Check This Out: <a href="https://www.benzinga.com/news/23/10/35265545/top-3-health-care-stocks-that-may-implode-this-quarter"> Top 3 Health Care Stocks That May Implode This Quarter</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer discretionary shares climbed by 1.4% on Monday.
In trading on Monday, energy shares rose by just 0.5%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The Charles Schwab Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schw#NYSE">SCHW</a>) reported better-than-expected earnings for the third quarter.
The company posted quarterly net revenue decline of 16% year-over-year to $4.61 billion, missing the consensus of $4.63 billion. Adjusted EPS stood at $0.77, down 30% Y/Y, exceeding the consensus of $0.75.
<h3>
Equities Trading UP</h3>
&nbsp;
Consolidated Communications Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsl#NASDAQ">CNSL</a>) shares shot up 16% to $4.10 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.
Shares of PCTEL, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcti#NASDAQ">PCTI</a>) got a boost, shooting 47% to $6.87. On Friday, Amphenol Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aph#NYSE">APH</a>) inked a deal to acquire PCTEL for around $139.7 million.
E2open Parent Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etwo#NYSE">ETWO</a>) shares were also up, gaining 26% to $3.09. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Aldeyra Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) shares dropped 67% to $1.80. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.
Shares of Streamline Health Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/strm#NASDAQ">STRM</a>) were down 67% to $0.2468 after the company announced it is undergoing a strategic restructuring to cut expenses.
Omeros Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omer#NASDAQ">OMER</a>) was down, falling 39% to $1.38 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35267375/jpmorgan-to-rally-over-29-here-are-10-other-analyst-forecasts-for-monday"> JPMorgan To Rally Over 29%? Here Are Top 10 Analyst Forecasts For Monday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.4% to $87.31 while gold traded down 0.4% at $1,934.00.
Silver traded down 0.4% to $22.805 on Monday while copper rose 0.3% to $3.5815.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were higher today. The eurozone&rsquo;s STOXX 600 rose 0.38%, London&rsquo;s FTSE 100 rose 0.59% while Spain&rsquo;s IBEX 35 Index rose 0.68% The German DAX rose 0.42% French CAC 40 rose 0.45%, while Italy&rsquo;s FTSE MIB Index gained 0.65%.
The Eurozone recorded a trade surplus of EUR 6.7 billion in August versus a year-ago gap of EUR 54.4 billion. The annual inflation rate in Italy eased to 5.3% in September from 5.4% a month ago. German wholesale prices fell for the sixth straight period by 4.1% year-over-year in September.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed lower on Monday, with Japan&rsquo;s Nikkei 225 falling 2.03%, China&rsquo;s Shanghai Composite Index falling 0.46% and Hong Kong&rsquo;s Hang Seng Index dropping 0.97%. India&rsquo;s S&amp;P BSE Sensex, meanwhile, slipped 0.2%.
India&#39;s wholesale prices fell by 0.26% year-over-year in September following a 0.52% decline in the previous month. Industrial production in Japan fell by 0.7% month-over-month in August.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index declined to -4.6 in October from 1.9 in the prior month, compared to market estimates for a reading of -7.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35266700/rain-oncology-and-3-other-stocks-under-1-insiders-are-buying"> Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying</a>

Nasdaq Gains 1%; Charles Schwab Earnings Top Views

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Consolidated Comms Hldgs (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnsl-stock-quote/">CNSL</a>) just reported results for the first quarter of 2024.<ul><li>Consolidated Comms Hldgs reported earnings per share of -27 cents. This was above the analyst estimate for EPS of -44 cents.</li><li>The company reported revenue of $274.68 million.</li><li>This was 0.43% better than the analyst estimate for revenue of $273.51 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/cnsl-stock-earnings-consolidated-comms-hldgs-for-q1-of-2024/">CNSL Stock Earnings: Consolidated Comms Hldgs Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CNSL Stock Earnings: Consolidated Comms Hldgs Beats EPS, Beats Revenue for Q1 2024

Consolidated Communications Q2 2024 Earnings Preview

Here is the next potential market catalyst

Consolidated Communications Non-GAAP EPS of -$0.37 beats by $0.06, revenue of $268.7M misses by $0.27M

Comments

Consolidated Comms Hldgs

Vendite allo scoperto

Consolidated Comms Hldgs (NASDAQ:CNSL) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO